Portable ultrasound provider SonoSite, Inc. has received 510(k) clearance from the Food & Drug Administration (FDA) for its fifth-generation EDGE™ ultrasound system.

The global market for medical ultrasound equipment is projected to reach $6.9 billion by 2017, reveals a report by Global Industry Analysts, Inc., San Jose, California.

Non-radiologist physicians have contributed to the widespread use of point-of-care (POC) ultrasound, but radiologists remain the primary users, according to a study in the November issue of the Journal of the American College of Radiology.

The U.S. Food and Drug Administration (FDA) has received a citizen petition from the International Contrast Ultrasound Society (ICUS), requesting that the agency remove black box warnings on ultrasound contrast agents.

The American College of Radiology (ACR) is looking for clinical reviewers for its ultrasound accreditation program.

Microvascular perfusion deficits and reduced arterial perfusion reserve are clearly detectable in patients with peripheral arterial disease (PAD) when dynamic contrast-enhanced ultrasound (CEUS) is used after transient arterial occlusion, report the authors of a feasibility study published online and in the August issue of Investigative Radiology.

Optison ™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent designed by GE Healthcare to improve suboptimal echocardiograms, may be used without concern about its affects on pulmonary arterial systolic pressure (PASP) or pulmonary vascular resistance (PVR), according to results of a study

Executing a partial substitution of ultrasound for CT in evaluating appendicitis could slash U.S. healthcare system expenditures by more than $1 billion, according to research conducted at Thomas Jefferson University in Philadelphia and presented at last week’s American Institute of Ultrasound in Medicine (AIUM) annual meeting.